[HTML][HTML] Filamentous bacteriophage: A prospective platform for targeting drugs in phage-mediated cancer therapy
P Garg - Journal of Cancer Research and Therapeutics, 2019 - journals.lww.com
A new modality of targeting therapeutic drugs based on the use of bacteriophage (virus), as
an emerging tool for specific targeting and for vaccine development, has been an area of …
an emerging tool for specific targeting and for vaccine development, has been an area of …
[HTML][HTML] Secreted protein acidic and rich in cysteine (SPARC) induces epithelial-mesenchymal transition, enhancing migration and invasion, and is associated with …
F López-Moncada, MJ Torres… - Asian Journal of …, 2019 - journals.lww.com
Secreted protein acidic and rich in cysteine (SPARC) is a matricellular protein highly
expressed in bone tissue that acts as a chemoattractant factor promoting the arrival of …
expressed in bone tissue that acts as a chemoattractant factor promoting the arrival of …
[HTML][HTML] Evaluation of the expression of matrix metalloproteinase-1 of laryngeal squamous cell carcinoma by ultrasound molecular imaging
Y Zhou, Z Song, Q Hu, X Ji, H Zheng… - Frontiers in …, 2019 - frontiersin.org
Purpose: The aims of this study were to evaluate the expression of matrix metalloproteinase-
1 (MMP-1) on laryngeal squamous cell carcinoma (LSCC) and improve the early diagnosis …
1 (MMP-1) on laryngeal squamous cell carcinoma (LSCC) and improve the early diagnosis …
Sparc induce transición epitelio-mesénquima aumentando las propiedades invasivas y migratorias del cáncer de próstata a través de integrina AVB3 y ZEB
FA López Moncada - 2019 - repositorio.uchile.cl
Introducción La proteína ácida secretada y rica en cisteína (SPARC) es una proteína
matricelular altamente expresada en el tejido óseo que actúa como un factor …
matricelular altamente expresada en el tejido óseo que actúa como un factor …